175277-73-3 Usage
General Description
ETHYL 2-CHLORO-3-CYANO-6-(TRIFLUOROMETHYL)-PYRIDINE-5-CARBOXYLATE is a chemical compound with the molecular formula C12H8ClF3N2O2. It is a pyridine derivative that contains an ethyl ester group and a trifluoromethyl group, as well as a cyano and chloro substituent. ETHYL 2-CHLORO-3-CYANO-6-(TRIFLUOROMETHYL)-PYRIDINE-5-CARBOXYLATE is used in the pharmaceutical and agrochemical industries as a building block for the synthesis of various compounds, including potential drug candidates and crop protection products. Its unique structure and reactivity make it a valuable intermediate for the production of diverse chemical products. However, due to its potential toxicity and environmental impact, proper handling and disposal procedures should be followed when working with this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 175277-73-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,7 and 7 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 175277-73:
(8*1)+(7*7)+(6*5)+(5*2)+(4*7)+(3*7)+(2*7)+(1*3)=163
163 % 10 = 3
So 175277-73-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H6ClF3N2.ClH/c8-5-1-4(7(9,10)11)3-13-6(5)2-12;/h1,3H,2,12H2;1H
175277-73-3Relevant articles and documents
A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor
Bach, Peter,Bostr?m, Jonas,Brickmann, Kay,Van Giezen,Hovland, Ragnar,Petersson, Annika U.,Ray, Asim,Zetterberg, Fredrik
, p. 2877 - 2881 (2011/06/24)
A novel series of P2Y12 antagonists for development of drugs within the antiplatelet area is presented. The synthesis of the piperazinyl-pyridine urea derivatives and their structure-activity relationships (SAR) are described. Several compounds
NEW PYRIDINE ANALOGUES
-
Page/Page column 54-55, (2008/06/13)
The present invention relates to certain new pyridin analogues of Formula ( I ) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular disease
